International: The vaccine, called Orthopoxvac, was developed by the Vektor laboratory in Siberia and registered by Russia's health ministry in 2022 following clinical trials, which, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback